Skip to search formSkip to main contentSkip to account menu

DZ2002

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal α-actinin-4 expression and stabilizing integrin-cytoskeleton linkage
BackgroundGlomerulonephritis is one of the major complications and causes of death in systemic lupus erythematosus (SLE) and is… 
2019
2019
67 Therapeutic and renal protective effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice
Background Glomerulonephritis is one of the major complications and causes of death in systemic lupus erythematosus (SLE). DZ2002… 
2018
2018
Assay development for determination of DZ2002, a new reversible SAHH inhibitor, and its acid metabolite DZA in blood and application to rat pharmacokinetic study
2016
2016
X-ray diffraction data for the 2.4 Angstrom Crystal Structure of S-adenosylhomocysteinase from Cryptosporidium parvum in Complex with DZ2002 and NAD (5TLS)
2008
2008
Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers.
2006
2006
S-Adenosyl-l-homocysteine Hydrolase Inactivation Curtails Ovalbumin-Induced Immune Responses
The reversible S-adenosyl-l-homocysteine (AdoHcy) hydrolase inhibitor methyl 4-(adenin-9-yl)-2-hydroxybutanoate (DZ2002… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)